The Future of Healthcare: Telehealth Revolution or Traditional Resilience?

blog-banner

Mark Wai


Share this Article

facebookXtwitterlinkedinmail

Don't miss an article.

Get most recent news and updates straight from Double Team!

The healthcare landscape is at a crossroads. On one path lies the disruptive potential of telehealth, promising accessible, virtual care that might revolutionize how we interact with doctors and manage our health. On the other hand, the enduring strength of traditional healthcare providers, built on established systems and in-person consultations, continues to hold a significant market share. Which future do you believe in? With Double, you can build investment strategies aligned with your views on this question. Let's see how:


The core question: Will telehealth become the dominant force in healthcare (Telehealth Growth), or will traditional healthcare providers maintain their leading role (Healthcare Today)?

We have constructed two equally-weighted portfolios designed to allow you to leverage your predictions in this matter, whether positive or negative, regarding the outcome of this question. These are both risky and concentrated strategies and may not be a fit for you. Rather, this is meant to showcase the power of Double investing tools and should not be considered financial advice. Remember all investing involves risk and these stocks could move for whatever reason, regardless of your choice.


Telehealth Growth (view strategy)

The potential benefits from telehealth cover a vast array of areas including virtual care adoption, remote monitoring and diagnostics, digital health infrastructure, and more.

  • Teladoc Health (TDOC): A known pure-play telehealth platform, offering virtual primary care and mental health services.
  • Amwell (AMWL): A telehealth infrastructure provider partnering with hospitals and insurers to scale virtual care.
  • Doximity (DOCS): A professional network connecting clinicians for virtual consults and telehealth workflows.
  • DexCom (DXCM): Continuous glucose monitors (CGMs) enable remote diabetes management.
  • Hims & Hers Health (HIMS): Direct-to-consumer telehealth for personalized prescriptions and wellness.
  • Veeva Systems (VEEV): Cloud software for life sciences, potentially accelerating digital clinical trials.
  • Microsoft (MSFT): Azure cloud powers telehealth platforms and AI-driven health analytics.
  • Cisco Systems (CSCO): Webex supports secure virtual consultations and hospital communications.
  • Oracle (ORCL): Oracle EHR (the acquisition of Cerner) integration may enable seamless telehealth data sharing.
  • Abbott Laboratories (ABT): Remote patient monitoring via devices like Freestyle Libre CGMs.

Healthcare Today (view strategy)

The established leaders in traditional healthcare focus on delivering proven in-person care, medical devices and pharmaceutical development pipelines. Even as the market shifts, these companies may maintain their significant roles in healthcare delivery.

  • HCA Healthcare (HCA): The largest U.S. hospital chain by bed size in 2024, reliant on in-person visits and surgeries.
  • Tenet Healthcare (THC): A hospital operator with limited telehealth integration.
  • Medtronic (MDT): A medical device company focused on in-hospital equipment (e.g., surgical robots).
  • Becton, Dickinson and Company (BDX): Focuses on physical diagnostic tools (e.g., syringes) with minimal digital health exposure.
  • UnitedHealth Group (UNH): An insurance giant still prioritizing in-network providers over telehealth.
  • Cigna (CI): May be slower to expand virtual care reimbursement compared to some rivals.
  • Pfizer (PFE): Relies on traditional drug development versus digital therapeutics.
  • Merck & Co. (MRK): A pharma leader with minimal investment in telehealth partnerships.
  • Quest Diagnostics (DGX): Lab testing reliant on physical sample collection sites.
  • Cardinal Health (CAH): A medical supplies distributor with low telehealth adjacency.
  • McKesson Corporation (MCK): A drug distribution company with minimal digital health innovation.

This blog post is for demonstrative and informational purposes only with regards to the tools offered by Double and is not financial advice.

Our Tools

See All

Fee Calculator

With zero AUM fees on Double, see how much savings a portfolio might accumulate compared to a traditional wealth advisor fee or ETF expense ratio.

empower-sm

0.89%

wealthfront-sm

0.25%

frec-sm

0.1%

1% Typical Advisor Fee

Tax Bracket Estimator

Estimate the taxes across federal, state, short term and long term for your situation.

Mark Wai


Share this Article

facebookXtwitterlinkedinmail

Our Tools

See All

Fee Calculator

With zero AUM fees on Double, see how much savings a portfolio might accumulate compared to a traditional wealth advisor fee or ETF expense ratio.

empower-sm

0.89%

wealthfront-sm

0.25%

frec-sm

0.1%

1% Typical Advisor Fee

Tax Bracket Estimator

Estimate the taxes across federal, state, short term and long term for your situation.

Don't miss an article.

Get most recent news and updates straight from Double Team!

Double is a registered investment adviser with the US Securities and Exchange Commission (SEC). While such registration does not imply a certain level of skill, it does require us to follow federal regulations that protect you, the investor. By law, we must provide investment advice that is in the best interest of our client. Please refer to Double's Form CRS for important additional information.

The publicly available portions of the Platform (i.e., the sections of the Platform that are available to individuals who are not party to a Client Agreement - including double.finance) are provided for educational purposes only and are not intended to provide legal, tax, or financial planning advice. To the extent that any of the content published on publicly available portions of the Platform may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Nothing on the publicly available portions of the Platform should be construed as a solicitation or offer, or recommendation, to buy or sell any security. All charts, figures, and graphs on the publicly available websites are for illustrative purposes only. Before investing, you should consider whether any investment, investment strategy, security, other asset, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You are also encouraged to consult your legal, tax, or investment professional regarding your specific situation. Registration does not imply a certain level of skill or training.

Investing involves risk. The value of your investment will fluctuate, and you may gain or lose money.

The contents of the Platform may contain forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates, and projections about the financial industry, the economy, or Global Predictions itself. Forward-looking statements are not guarantees of the underlying expected actions or future performance and future results may differ significantly from those anticipated by the forward-looking statements. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements.

¹ Data as of July 2024.

² Availability of tax loss harvesting depends on portfolio diversity.

³ As of November 8, 2024. The optional Cash Sweep program takes the cash sitting in your brokerage account and moves it to an FDIC-insured interest-earning deposit account. The current yield is 1.0%, rates subject to change at any time. The cash sweep program is made available in coordination with Apex Clearing Corporation. Please read the Important Disclosures for more information.

⁴ This analysis calculator tool is for illustrative purposes only and is not financial advice. We do not guarantee the accuracy of the results or their relevance to your particular circumstances. This calculator uses hypothetical historical data and does not take into account the effect of taxes on a taxable account. Hypothetical historical data is no guarantee of future performance and this calculator is not intended to predict actual performance. The input of different time periods, amounts, and fees will vary calculator results. Average ETF fee is based on the AUM weighted average of US ETFs as of September 2024, see more information. Note that you can purchase ETFs through Double, which may incur additional fees.

Full pricing details along with an FAQ can be found here

Data displayed in charts and graphics above are for illustrative purposes only and do not reflect actual investment results and are not a guarantee of future results.

By using double.finance, you accept our and . Double is only available to US residents.

See Double Finance Form ADV Part IIA for additional information. Double does not guarantee that the results of its advice, recommendations, or the objectives of its direct index or cash management strategies will be achieved. We make no assurance that the investment process will consistently lead to successful investing. Before you invest, you should carefully review and consider your investment objectives as well as the risks, charges, and expenses of the underlying securities. There is at least a $1,000 account minimum required to participate in Double's strategies, although some strategies may have higher minimums.

Double does not provide tax, or legal advice. Double's website, brokerage, and advisory services are not intended for persons of any jurisdiction where Double is not authorized to do business. Tax savings will vary from client to client due to many factors including market conditions, tax characteristics of securities, client-imposed investment restrictions, client tax rate or status, and changes in tax regulations.